Total Revenue

+16% (from $606.56M in Q1 2024 to $702.889M in Q1 2025)

Total Revenue increased by $96.329M YoY, driven by robust market demand and operational expansion that built upon prior period initiatives, including diversified revenue streams that had already begun to benefit from merger impacts and recovery trends. " "

Outpatient Medical Revenue

+34% (from $238.27M in Q1 2024 to $320.548M in Q1 2025)

Outpatient Medical Revenue surged by $82.278M, reflecting strong service demand, higher occupancy, and increased rental rates per square foot, continuing the momentum from previous period strategies and portfolio enhancements. " "

Other Non-reportable Revenue

+180%+ (from $5.06M in Q1 2024 to $14.332M in Q1 2025)

Other Non-reportable Revenue jumped significantly as a result of improved performance from non-core investments, including joint ventures, and favorable market conditions that amplified revenue from investments initiated in previous periods. " "

Net Income (applicable to common shares)

+347% (from $11,177K in Q1 2024 to $50,064K in Q1 2025)

Net Income expanded dramatically due to improved operational efficiencies, margin expansion, and cost control measures—benefits from post-merger synergies and strategic initiatives implemented in prior periods that continued to yield significant financial benefits in Q1 2025. " "